North America Injectable Anticoagulants Market by Manufacturers, Countries, Type and Application, Forecast to 2022

April 2017 | 122 pages | ID: N1E51EDD74FEN
GlobalInfoResearch

Abstracts

'The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin?], enoxaparin [Lovenox?]) and factor Xa inhibitors (fondaparinux [Arixtra?]).

In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.'

Scope of the Report:

This report focuses on the Injectable Anticoagulants in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• Sanofi
• Genentech (Roche)
• Boehringer Ingelheim
• Pfizer
• The Medicines Company
• Aspen
• Otsuka

Market Segment by Countries, covering

• United States
• Canada
• Mexico

Market Segment by Type, covers

• Low-molecular-weight Heparin (LMWH)
• Direct Thrombin Inhibitor (DTI)
• Other

Market Segment by Applications, can be divided into

• VTE
• ACS/MI
• AF
• Other

There are 15 Chapters to deeply display the North America Injectable Anticoagulants market.

Chapter 1, to describe Injectable Anticoagulants Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Injectable Anticoagulants, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Injectable Anticoagulants, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Injectable Anticoagulants market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Injectable Anticoagulants Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Injectable Anticoagulants Introduction
1.2 Market Analysis by Type
  1.2.1 Low-molecular-weight Heparin (LMWH)
  1.2.2 Direct Thrombin Inhibitor (DTI)
  1.2.3 Other
1.3 Market Analysis by Applications
  1.3.1 VTE
  1.3.2 ACS/MI
  1.3.3 AF
  1.3.4 Other
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Sanofi
  2.1.1 Profile
  2.1.2 Injectable Anticoagulants Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Sanofi Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Sanofi News
2.2 Genentech (Roche)
  2.2.1 Profile
  2.2.2 Injectable Anticoagulants Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Genentech (Roche) News
2.3 Boehringer Ingelheim
  2.3.1 Profile
  2.3.2 Injectable Anticoagulants Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Boehringer Ingelheim News
2.4 Pfizer
  2.4.1 Profile
  2.4.2 Injectable Anticoagulants Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Pfizer Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Pfizer News
2.5 The Medicines Company
  2.5.1 Profile
  2.5.2 Injectable Anticoagulants Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 The Medicines Company Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 The Medicines Company News
2.6 Aspen
  2.6.1 Profile
  2.6.2 Injectable Anticoagulants Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Aspen Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Aspen News
2.7 Otsuka
  2.7.1 Profile
  2.7.2 Injectable Anticoagulants Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Otsuka Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Otsuka News

3 NORTH AMERICA INJECTABLE ANTICOAGULANTS MARKET COMPETITION, BY MANUFACTURER

3.1 North America Injectable Anticoagulants Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Injectable Anticoagulants Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Injectable Anticoagulants Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Injectable Anticoagulants Manufacturer Market Share
  3.4.2 Top 5 Injectable Anticoagulants Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA INJECTABLE ANTICOAGULANTS MARKET ANALYSIS BY COUNTRIES

4.1 North America Injectable Anticoagulants Sales Market Share by Countries
4.2 North America Injectable Anticoagulants Sales by Countries (2012-2017)
4.3 North America Injectable Anticoagulants Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION INJECTABLE ANTICOAGULANTS BY TYPE

5.1 North America Injectable Anticoagulants Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Injectable Anticoagulants Sales and Market Share by Type (2012-2017)
  5.1.2 North America Injectable Anticoagulants Revenue and Market Share by Type (2012-2017)
5.2 Low-molecular-weight Heparin (LMWH) Sales Growth and Price
  5.2.1 North America Low-molecular-weight Heparin (LMWH) Sales Growth (2012-2017)
  5.2.2 North America Low-molecular-weight Heparin (LMWH) Price (2012-2017)
5.3 Direct Thrombin Inhibitor (DTI) Sales Growth and Price
  5.3.1 North America Direct Thrombin Inhibitor (DTI) Sales Growth (2012-2017)
  5.3.2 North America Direct Thrombin Inhibitor (DTI) Price (2012-2017)
5.4 Other Sales Growth and Price
  5.4.1 North America Other Sales Growth (2012-2017)
  5.4.2 North America Other Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION INJECTABLE ANTICOAGULANTS BY APPLICATION

6.1 North America Injectable Anticoagulants Sales Market Share by Application (2012-2017)
6.2 VTE Sales Growth (2012-2017)
6.3 ACS/MI Sales Growth (2012-2017)
6.4 AF Sales Growth (2012-2017)
6.5 Other Sales Growth (2012-2017)

7 UNITED STATES INJECTABLE ANTICOAGULANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Injectable Anticoagulants Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Injectable Anticoagulants Sales and Market Share by Type
7.3 United States Injectable Anticoagulants Sales by Application (2012-2017)
7.4 United States Injectable Anticoagulants Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Injectable Anticoagulants Sales and Market Share by Manufacturer
  7.4.2 United States Injectable Anticoagulants Revenue and Market Share by Manufacturer
7.5 United States Injectable Anticoagulants Export and Import (2012-2017)

8 CANADA INJECTABLE ANTICOAGULANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Injectable Anticoagulants Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Injectable Anticoagulants Sales and Market Share by Type
8.3 Canada Injectable Anticoagulants Sales by Application (2012-2017)
8.4 Canada Injectable Anticoagulants Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Injectable Anticoagulants Sales and Market Share by Manufacturer
  8.4.2 Canada Injectable Anticoagulants Revenue and Market Share by Manufacturer
8.5 Canada Injectable Anticoagulants Export and Import (2012-2017)

9 MEXICO INJECTABLE ANTICOAGULANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Injectable Anticoagulants Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Injectable Anticoagulants Sales and Market Share by Type
9.3 Mexico Injectable Anticoagulants Sales by Application (2012-2017)
9.4 Mexico Injectable Anticoagulants Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Injectable Anticoagulants Sales and Market Share by Manufacturer
  9.4.2 Mexico Injectable Anticoagulants Revenue and Market Share by Manufacturer
9.5 Mexico Injectable Anticoagulants Export and Import (2012-2017)

10 INJECTABLE ANTICOAGULANTS MARKET FORECAST (2017-2022)

10.1 North America Injectable Anticoagulants Sales, Revenue and Growth Rate (2017-2022)
10.2 Injectable Anticoagulants Market Forecast by Countries (2017-2022)
  10.2.1 United States Injectable Anticoagulants Forecast (2017-2022)
  10.2.2 Canada Injectable Anticoagulants Forecast (2017-2022)
  10.2.3 Mexico Injectable Anticoagulants Forecast (2017-2022)
10.3 Injectable Anticoagulants Market Forecast by Type (2017-2022)
10.4 Injectable Anticoagulants Market Forecast by Application (2017-2022)

11 INJECTABLE ANTICOAGULANTS MANUFACTURING COST ANALYSIS

11.1 Injectable Anticoagulants Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Injectable Anticoagulants

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Injectable Anticoagulants Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Injectable Anticoagulants Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Injectable Anticoagulants Picture
Table Product Specifications of Injectable Anticoagulants
Figure North America Sales Market Share of Injectable Anticoagulants by Types in 2016
Table Types of Injectable Anticoagulants
Figure Low-molecular-weight Heparin (LMWH) Picture
Table Major Manufacturers of Low-molecular-weight Heparin (LMWH)
Figure Direct Thrombin Inhibitor (DTI) Picture
Table Major Manufacturers of Direct Thrombin Inhibitor (DTI)
Figure Other Picture
Table Major Manufacturers of Other
Table North America Injectable Anticoagulants Sales Market Share by Applications in 2016
Table Applications of Injectable Anticoagulants
Figure VTE Picture
Figure ACS/MI Picture
Figure AF Picture
Figure Other Picture
Figure United States Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Injectable Anticoagulants Type and Applications
Table Sanofi Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table Genentech (Roche) Injectable Anticoagulants Type and Applications
Table Genentech (Roche) Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Injectable Anticoagulants Type and Applications
Table Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Injectable Anticoagulants Type and Applications
Table Pfizer Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table The Medicines Company Basic Information, Manufacturing Base and Competitors
Table The Medicines Company Injectable Anticoagulants Type and Applications
Table The Medicines Company Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aspen Basic Information, Manufacturing Base and Competitors
Table Aspen Injectable Anticoagulants Type and Applications
Table Aspen Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Injectable Anticoagulants Type and Applications
Table Otsuka Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Injectable Anticoagulants Sales by Manufacturer (2016-2017)
Figure North America Injectable Anticoagulants Sales Market Share by Manufacturer in 2016
Figure North America Injectable Anticoagulants Sales Market Share by Manufacturer in 2017
Table North America Injectable Anticoagulants Revenue by Manufacturer (2016-2017)
Figure North America Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure North America Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017
Table North America Injectable Anticoagulants Price by Manufacturers (2016-2017)
Figure Top 3 Injectable Anticoagulants Manufacturer Market Share in 2016
Figure Top 3 Injectable Anticoagulants Manufacturer Market Share in 2017
Figure Top 5 Injectable Anticoagulants Manufacturer Market Share in 2016
Figure Top 5 Injectable Anticoagulants Manufacturer Market Share in 2017
Figure North America Injectable Anticoagulants Sales and Growth (2012-2017)
Table North America Injectable Anticoagulants Sales by Countries (2012-2017)
Table North America Injectable Anticoagulants Sales Market Share by Countries (2012-2017)
Figure North America 2012 Injectable Anticoagulants Sales Market Share by Countries
Figure North America 2016 Injectable Anticoagulants Sales Market Share by Countries
Figure North America Injectable Anticoagulants Revenue and Growth (2012-2017)
Table North America Injectable Anticoagulants Revenue by Countries (2012-2017)
Table North America Injectable Anticoagulants Revenue Market Share by Countries (2012-2017)
Table North America 2012 Injectable Anticoagulants Revenue Market Share by Countries
Table North America 2016 Injectable Anticoagulants Revenue Market Share by Countries
Table North America Injectable Anticoagulants Sales by Type (2012-2017)
Table North America Injectable Anticoagulants Sales Share by Type (2012-2017)
Table North America Injectable Anticoagulants Revenue by Type (2012-2017)
Table North America Injectable Anticoagulants Revenue Share by Type (2012-2017)
Figure North America Low-molecular-weight Heparin (LMWH) Sales Growth (2012-2017)
Figure North America Low-molecular-weight Heparin (LMWH) Price (2012-2017)
Figure North America Direct Thrombin Inhibitor (DTI) Sales Growth (2012-2017)
Figure North America Direct Thrombin Inhibitor (DTI) Price (2012-2017)
Figure North America Other Sales Growth (2012-2017)
Figure North America Other Price (2012-2017)
Table North America Injectable Anticoagulants Sales by Application (2012-2017)
Table North America Injectable Anticoagulants Sales Share by Application (2012-2017)
Figure North America VTE Sales Growth (2012-2017)
Figure North America ACS/MI Sales Growth (2012-2017)
Figure North America AF Sales Growth (2012-2017)
Figure North America Other Sales Growth (2012-2017)
Figure United States Injectable Anticoagulants Revenue and Growth (2012-2017)
Figure United States Injectable Anticoagulants Sales and Growth (2012-2017)
Table United States Injectable Anticoagulants Sales by Type (2012-2017)
Table United States Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Table United States Injectable Anticoagulants Sales by Application (2012-2017)
Table United States Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Table United States Injectable Anticoagulants Sales by Manufacturer (2016-2017)
Figure United States Injectable Anticoagulants Sales Market Share by Manufacturer in 2016
Figure United States Injectable Anticoagulants Sales Market Share by Manufacturer in 2017
Table United States Injectable Anticoagulants Revenue by Manufacturer (2016-2017)
Figure United States Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure United States Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017
Table United States Injectable Anticoagulants Export and Import (2012-2017)
Figure Canada Injectable Anticoagulants Revenue and Growth (2012-2017)
Figure Canada Injectable Anticoagulants Sales and Growth (2012-2017)
Table Canada Injectable Anticoagulants Sales by Type (2012-2017)
Table Canada Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Table Canada Injectable Anticoagulants Sales by Application (2012-2017)
Table Canada Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Table Canada Injectable Anticoagulants Sales by Manufacturer (2016-2017)
Figure Canada Injectable Anticoagulants Sales Market Share by Manufacturer in 2016
Figure Canada Injectable Anticoagulants Sales Market Share by Manufacturer in 2017
Table Canada Injectable Anticoagulants Revenue by Manufacturer (2016-2017)
Figure Canada Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure Canada Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017
Table Canada Injectable Anticoagulants Export and Import (2012-2017)
Figure Mexico Injectable Anticoagulants Revenue and Growth (2012-2017)
Figure Mexico Injectable Anticoagulants Sales and Growth (2012-2017)
Table Mexico Injectable Anticoagulants Sales by Type (2012-2017)
Table Mexico Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Table Mexico Injectable Anticoagulants Sales by Application (2012-2017)
Table Mexico Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Table Mexico Injectable Anticoagulants Sales by Manufacturer (2016-2017)
Figure Mexico Injectable Anticoagulants Sales Market Share by Manufacturer in 2016
Figure Mexico Injectable Anticoagulants Sales Market Share by Manufacturer in 2017
Table Mexico Injectable Anticoagulants Revenue by Manufacturer (2016-2017)
Figure Mexico Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure Mexico Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017
Table Mexico Injectable Anticoagulants Export and Import (2012-2017)
Figure North America Injectable Anticoagulants Sales, Revenue and Growth Rate (2017-2022)
Table North America Injectable Anticoagulants Sales Forecast by Countries (2017-2022)
Table North America Injectable Anticoagulants Market Share Forecast by Countries (2017-2022)
Figure United States Injectable Anticoagulants Sales Forecast (2017-2022)
Figure Canada Injectable Anticoagulants Sales Forecast (2017-2022)
Figure Mexico Injectable Anticoagulants Sales Forecast (2017-2022)
Table North America Injectable Anticoagulants Sales Forecast by Type (2017-2022)
Table North America Injectable Anticoagulants Market Share Forecast by Type (2017-2022)
Table North America Injectable Anticoagulants Sales Forecast by Application (2017-2022)
Table North America Injectable Anticoagulants Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Injectable Anticoagulants
Figure Manufacturing Process Analysis of Injectable Anticoagulants
Figure Injectable Anticoagulants Industrial Chain Analysis
Table Raw Materials Sources of Injectable Anticoagulants Major Manufacturers in 2016
Table Major Buyers of Injectable Anticoagulants
Table Distributors/Traders/ Dealers List